Literature DB >> 27441022

Letters to the Editor.

Karen Chang1, Dennis Gurwitz2, Peter Azzopardi3, Shaheen Doctor4, Ronik Kanani5, Constantine Petrou6, Paul Meinert7, Meera Umamaheswaran Kissoon8.   

Abstract

Year:  2016        PMID： 27441022      PMCID： PMC4933058          DOI： 10.1093/pch/21.5.260

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  27 in total

1.  Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab.

Authors:  Pascal M Lavoie; Alfonso Solimano; Richard Taylor; Eddie Kwan; Jennifer Claydon; Stuart E Turvey; Nico Marr
Journal:  JAMA Pediatr       Date:  2016-02       Impact factor: 16.193

2.  Growth rate of lung function in healthy preterm infants.

Authors:  Luciana Friedrich; Paulo M C Pitrez; Renato T Stein; Marcelo Goldani; Robert Tepper; Marcus H Jones
Journal:  Am J Respir Crit Care Med       Date:  2007-09-20       Impact factor: 21.405

3.  Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age.

Authors:  Maike Vom Hove; Freerk Prenzel; Holm H Uhlig; Eva Robel-Tillig
Journal:  J Pediatr       Date:  2013-09-20       Impact factor: 4.406

4.  Quality of reporting and evidence in American Academy of Pediatrics guidelines.

Authors:  Andre Isaac; Michael Saginur; Lisa Hartling; Joan L Robinson
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

5.  Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.

Authors:  S Broughton; R Bhat; A Roberts; M Zuckerman; G Rafferty; A Greenough
Journal:  Arch Dis Child       Date:  2005-09-27       Impact factor: 3.791

6.  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.

Authors:  Nele Sigurs; Fatma Aljassim; Bengt Kjellman; Paul D Robinson; Fridrik Sigurbergsson; Ragnar Bjarnason; Per M Gustafsson
Journal:  Thorax       Date:  2010-06-27       Impact factor: 9.139

7.  School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants.

Authors:  A Greenough; J Alexander; P Boit; J Boorman; S Burgess; A Burke; P A Chetcuti; I Cliff; W Lenney; T Lytle; C Morgan; C Raiman; N J Shaw; K P Sylvester; J Turner
Journal:  Thorax       Date:  2009-02-12       Impact factor: 9.139

Review 8.  The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection.

Authors:  Shelagh M Szabo; Katherine L Gooch; Meagan M Bibby; Pamela G Vo; Ian Mitchell; Pamela Bradt; Adrian R Levy
Journal:  Paediatr Respir Rev       Date:  2013-01       Impact factor: 2.726

9.  Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia.

Authors:  Douglas F Willson; Christopher P Landrigan; Susan D Horn; Randall J Smout
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

Review 10.  Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective.

Authors:  Nusrat Homaira; William Rawlinson; Thomas L Snelling; Adam Jaffe
Journal:  Int J Pediatr       Date:  2014-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.